Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEP-33457 (Forigerimod) in Systemic Lupus Erythematosus
NCT01135459Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jun 2010
- Primary completion
- Jan 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 2 trial of forigerimod in systemic lupus erythematosus (SLE), sponsored by Cephalon, Inc.. Started Jun 2010; status: completed.
02
Drugs
forigerimod
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01135459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135459.